Lanean...
Interim treatment: Bridging delays to opioid treatment access
OBJECTIVE: Despite the undisputed effectiveness of agonist maintenance for opioid dependence, individuals can remain on waitlists for months, during which they are at significant risk for morbidity and mortality. To mitigate these risks, the Food and Drug Administration in 1993 approved interim trea...
Gorde:
| Argitaratua izan da: | Prev Med |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4592374/ https://ncbi.nlm.nih.gov/pubmed/25937593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ypmed.2015.04.017 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|